Clinical Trials

TEMPO:
Prader-Willi Syndrome

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome

RECONNECT:
Fragile X Syndrome

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of ZYN002 in Children, Adolescents, and Young Adults with Fragile X Syndrome

ARGUS:
Dravet Syndrome

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EPX-100 as Adjunctive Therapy in Children and Adults with Dravet Syndrome